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Background: To date, HIV/AIDS remains a threat of the 21st century. The overall rate of 
new HIV infection continues to decline in several countries, but there is still a remarkable 
burden of disease seen in sub-Saharan Africa. Several studies observed that 70% to 90% of 
HIV-infected patients present with ear, nose and throat symptoms. The aim of this study was 
to identify the magnitude of ENT manifestations among HIV-infected patients attended HIV 
clinics at KCMC based on age, sex, and CD4 count.
Methods: This was a descriptive cross-sectional study conducted at KCMC hospital invol-
ving HIV-infected patients who attended HIV clinics from February to July 2018. 
Convenient sampling was employed to get study participants, and 200 patients were recruited 
in the study. Data were collected through a questionnaire from patients, and results were 
analyzed using SPSS version 20.
Results: Sixty-eight (34%) of 200 HIV-infected patients had ENT manifestations. The most 
affected age group was 0–9 years. ENT manifestations were more prevalent in females 
(23.5%) than in males (10.5%). Those with CD4 count less than 200cells/µL also it was a 
high prevalence (56.3%).
Conclusion: This study observed that one-third of the studied population had ENT mani-
festations. All medical practitioners should be aware of ENT manifestations in HIV-infected 
patients in order to assure early and appropriate intervention.
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Background
Human immunodeficiency virus (HIV) is a retrovirus that infects cells of the 
immune system impairing their function and results in deterioration of the immune 
system. The virus infects and damages helper T-cells, weakens both cell-mediated 
and humoral immunity, and increases susceptibility to encapsulated organisms such 
as Streptococcus pneumoniae and other bacteria. Destruction of both cell-mediated 
and humoral immunity predisposes an individual to develop acquired immunode-
ficiency syndrome (AIDS) with ear nose and throat (ENT) manifestation. 
Commonly reported ENT manifestations in HIV-positive patients include; oral 
candidiasis, lymph node enlargement, rhinosinusitis, allergic rhinitis, lymph node 
enlargement in the neck, adenoid enlargement, and chronic suppurative otitis 
media.1–8
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Several studies have observed that 70% to 90% of 
HIV-infected patients will present with ear, nose and throat 
symptoms, so our research aimed to identify the preva-
lence of ENT manifestations among clients attending HIV- 
clinics at KCMC. Knowing the prevalence will create a 
high index of suspicion to physicians and health-care 
providers in encouraging HIV testing to patients present-
ing to hospital with ENT symptoms. Also, by knowing 
how commonly used HIV clinical markers associated with 
ENT manifestations, it will be possible to devise ENT 
screening schedules for clients of HIV-clinics.
Methods
Study Design and Time
This was a descriptive hospital-based cross-sectional study 
conducted from February to July 2018.
Study Area
This study was conducted at Kilimanjaro Christian 
Medical Centre, a consultant hospital in Kilimanjaro, 
Northern Tanzania, serving a population of approximately 
7,503,807 inhabitants. It is the only hospital with an ENT 
department in the zone. In addition to the ENT clinic, the 
hospital has three dedicated HIV clinics, namely Care and 
Treatment Clinic (CTC), Child-Centred Family Care 
Clinic (CCFCC), Infectious Disease Clinic (IDC) which 
also served as a setting for this study.
Study Population
All HIV-positive patients both adult and children who 
attended any of the HIV clinics or the ENT clinic were 
recruited and invited to participate in the study.
Inclusion Criteria
We included all patients who were HIV test positive 
attending at any of the clinics and ENT clinic during the 
study period.
Exclusion Criteria
Patients or care takers who were not willing to participate 
in the study were excluded.
Variables
The main outcome of interest in this study were adenoids 
hypertrophy, allergic rhinitis, cervical lymphadenopathy, 
CSOM, laryngitis, esophageal candidiasis, oral candidia-
sis, otitis externa, rhinosinusitis, Sensorineural hearing 
loss (SNHL) and tonsillitis, the independent variables 
being age, sex and CD4 count.
Data Collection Tools and Methods
Potential study participants in HIV clinics were 
approached by a researcher and consented to participate 
in the study. A pretested questionnaire was used to capture 
the patient’s demographic and illness history. A headlight 
and otoscope were then employed by the researcher to 
examine the ears, nose and throat of the patient in an 
attempt to identify any ENT condition, fiberoptic nasolar-
yngoscope was used at the ENT clinic to examine patients 
whom we suspected to have nasopharyngeal tumor or 
history of nasal bleeding. The findings of the examination 
were recorded along with the demographic and clinical 
history.
Ethical Clearance
This study adheres to Declaration of Helsinki, ethical 
clearance was obtained from KCMUCo Research Ethics 
Committee with certificate number 2373. For all those 
who were identified as having an ENT condition were 
channeled towards the appropriate treatment avenues.
Data Analysis
Data entry, cleaning, and analysis were done using IBM® 
SPSS® version 24. Descriptive analysis was done for all 
variables studied; continuous data were summarized into 
measures of central tendency with their respective mea-
sures of dispersion. Categorical data were summarized into 
frequencies and percentage.
Results
Demographic Characteristics of Study 
Participants
Two-hundred HIV seropositive patients that attended at 
KCMC hospital between February and July 2018 were 
studied to determine the magnitude and distribution of 
ENT manifestations by age, sex and CD4 count. All 
patients were already enrolled on highly active antiretro-
viral therapy (HAART) by the time of this study. Their age 
ranged from 4 to 78 years (median age of 40 years). 
Majority of participants were females 135 (67.5%). The 
demographic characteristics of participants are shown in 
(Table 1).
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Distribution of Clinical ENT 
Manifestations
Rhinosinusitis was the most common clinical manifesta-
tion, present in 13 (24%) out of 68 patients who pre-
sented with ENT manifestations. The distribution of 
other clinical ENT manifestations is summarized in 
(Figure 1).
Proportion of HIV Seropositive Patients 
Presenting with ENT Manifestations by 
Age
During the study period, 68 (34%) patients out of 200 
presented with ENT manifestations. Most cases were in 
the age group of 40–49 but in terms of proportions within 
the age groups, the highest proportions were in the age 
groups 0–9 years (50%), and 14 in 50–59 years (45.2%). 
Table 2 shows the ENT manifestations that we saw in the 
study participants.
ENT Manifestations Among HIV 
Seropositive Patients by Sex
The prevalence of ENT manifestations among females was 
higher (23.5%) compared to males (10.5%). This differ-
ence was however not statistically significant (Table 3).








































Figure 1 Distribution of ENT clinical manifestations.
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ENT Manifestations Among HIV-Infected 
Patients by CD4 Count
ENT manifestations among patients with CD4 count less 
than 200 cells/µL were seen in 56.3% of patients, while 
amongst those with a CD4 count between 200 and 499 
cells/µL, they were in 52.5% of patients, and in those 
with CD4 count greater or equal to 500 cells/µL, 34% 
(Table 4).
Discussion
The prevalence of ENT manifestations amongst the 200 
HIV-positive participants we recruited in our study was 
34%; which is comparable to that in a study done at 
Muhimbili National Hospital by Swai who reported a 
prevalence of 34.1%.9 Both of these studies however 
show a marked contrast to a prevalence of 61.8% reported 
in Iran by Jafari et al We postulate this difference to be due 
to the difference in sample size as Jafari study had a 
sample size of 98.10
A 2006 study in India with a sample size of 968 HIV 
seropositive patients reported a prevalence of 79% for ENT 
manifestations.4 At the time of the India study, not all patients 
were on HAART, making it likely that they had lower CD4 
counts compared to our patients, and thus they had a higher 
prevalence. Our finding of patients with low CD4 having 
more ENT manifestations supports this hypothesis.
In this study, 3(50%) patients in the age group 0–9 
years showed a higher prevalence of ENT manifestations 
and 6(23.1%) patients of age group 20–29 years were the 
least prevalent with ENT manifestations. In comparison, a 
study done at Muhimbili National hospital observed the 
most prevalent age group was 20–29 years in 12 (50%) 
patients while the least prevalent group was 50–59 years 
with 7(24.1%) patients.9 We speculate this difference to be 
the result of numbers.
Our study did not find any statistical association between 
sex and the ENT manifestations, despite the proportion of 
females with ENT complaints being higher. This is contrary 
to a study done at Muhimbili National Hospital where the 
prevalence of ENT manifestations was higher among males 
35.7% than female 33.3%; this was however not statistically 
significant.9 In Iran, ENT manifestations have also been 
found to be higher in men compared to women but this was 
also not statistically significant.10 Empowerment of women 
in our study area and the better health seeking behavior of 
men compared to women might have contributed to the 
higher proportion of women in our study.
We found that ENT manifestations decreased as CD4 
counts increased. Swai in Muhimbili Tanzania found a 
similar trend. It is plausible that as a person’s CD4 count 
drops and the person becomes more prone to opportunistic 
infections, the likely hood of developing ENT manifesta-
tions as part of the opportunistic infections increases.9 
Some ENT conditions are recognized as opportunistic 
infections in HIV and have been used in the WHO clinical 
staging of HIV.11
Table 2 ENT Manifestations According to Age Groups (N=200)
Age (Years) Presence of ENT Manifestations N (%)
0–9 Yes 3 (50)
No 3 (50)
10–19 Yes 9 (28.1)
No 23 (71.9)
20–29 Yes 6 (23.1)
No 20 (76.9)
30–39 Yes 11 (36.7)
No 19 (63.3)
40–49 Yes 20 (35.7)
No 36 (64.3)
50–59 Yes 14 (45.2)
No 17 (54.8)
≥60 Yes 5 (26.3)
No 14 (73.7)
Table 3 ENT Manifestations by Sex (N=200)
ENT Manifestation
Yes No Total
Sex Male 21 44 65
Female 47 88 135
68 132 200
Notes: Chi square, 0.12; P-value, 0.73.
Table 4 ENT Manifestations by CD4 Count (N=200)
ENT Manifestation
Yes No Total
CD4 count <200cells/µL 9 7 16
200–499cells/µL 32 29 61
≥500cells/µL 27 96 123
68 132 200
Notes: Chi square, 20.75; P-value, <0.01.
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Although this study succeeded in highlighting some 
common ENT manifestations, it was limited in the number 
of patients that were reached due to time limitations. Also, 
being conducted in a tertiary hospital, it is possible that 
milder ENT manifestations may exist in lower health 
facilitates and are not picked up by clinicians.
Conclusion
Of the 200 HIV-positive patients we examined, 34% had 
ENT manifestations. These were however not their pre-
senting complaints and were uncovered as a result of our 
screening. We found that as CD4 count drop, there more 
patients had ENT manifestations. We therefore recom-
mend that all clients seeking care at HIV-clinics, particu-
larly those with CD4 counts below 500 cells/µL be 
screened for ENT conditions.
What is Known About This Topic?
HIV is the most common cause of AIDS; several studies 
have documented that 70% to 90% of HIV-infected 
patients will present with ENT manifestations during the 
course of the disease. Even asymptomatic HIV patients 
tend to have ENT conditions when screened.
What This Study Adds
The need to screen HIV patients for ENT conditions parti-
cularly those with low CD4 counts.
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